LYPD1 anticorps (C-Term)
Aperçu rapide pour LYPD1 anticorps (C-Term) (ABIN2304754)
Antigène
Voir toutes LYPD1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 100-130, C-Term
-
Réactivité croisée
- Humain, Souris
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu Mo
-
Attributs du produit
- LYPD1, CT (LYPD1, LYPDC1, Ly6/PLAUR domain-containing protein 1, Putative HeLa tumor suppressor)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- LYPD1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 100~130 amino acids from the C-terminal region of human LYPD1.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- LYPD1 (Ly6/Plaur Domain Containing 1 (LYPD1))
-
Autre désignation
- LYPD1
-
UniProt
- Q8N2G4
Antigène
-